Day: June 1, 2019

June 2019 Editorial Message

VOL. 12, NO. 6 • JUNE 2019 Dear Colleagues:  Welcome to the June 2019 issue of The Journal of Clinical and Aesthetic Dermatology (JCAD). In this issue, we are pleased to present the article “Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS),” by Del Rosso, Tanghetti, Webster, Stein Gold,


Letters to the Editor: Long-term Treatment with Tofacitinib in Severe Alopecia Areata: An Update

Dear Editor: Tofacitinib is a Janus kinase (JAK) 1/3 inhibitor that has been approved by the United States Food and Drug Administration for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. An increasing number of studies have demonstrated the efficacy of tofacitinib in treatment of alopecia areata (AA).1–6 Treatment duration in these studies


Coprescription of Isotretinoin and Systemic Corticosteroids for Acne: An Analysis of the National Ambulatory Medical Care Survey

 J Clin Aesthet Dermatol. 2019;12(6):27–28 by Brooke Vasicek, MD; William Adams, PhD; Laryn Steadman, BFA; Jeave Reserva, MD; and James Swan, MD Drs. Vasicek, Reserva, and Swan are with the Division of Dermatology at the Loyola University Medical Center in Hines, Illinois. Dr. Adams is with the Biostatistics Core, Health Sciences Division at the Loyola University